The Next Frontier – Emerging Opportunities in the LATAM Pharma Market

What will this webinar address?

The LATAM pharma market has experienced significant development in recent years. Valued at 98 billion USD and with expected growth of 10.1%, the LATAM market will go above both developed markets like North America (3.1%) and Europe (3.9%), highlighting its significance. From increased focus on innovation and expansion of local manufacturing to the growth of biotechnology and biosimilars, the LATAM market offers an attractive destination for international pharma for clinical trials and investment in local manufacturing sites.

While the potential is huge, barriers still exist in the shape of technology gaps, supply chain constraints and heavy reliance on API imports. Despite these challenges, progress is being made through local and international collaboration, paving the way for an exciting future for LATAM pharma.

Join our latest webinar to hear expert opinion on the opportunities the LATAM market can bring to the global stage, and why the industry should take notice of its possibilities.

• Assessing the expansion of local manufacturing capabilities and the export opportunities it brings to the global market
• Reviewing the potential of Latin America to become a prominent CMO hub, and the value it brings to the industry
• Tech advancements for improving R&D and manufacturing outcomes
• Why collaboration between drug manufacturers, government bodies and international pharma is essential for innovation and development.